Not All Exits Are Equal Anymore

The most revealing detail in private equity this month was not that Sycamore Partners wanted out of Boots. It was more which door it chose. A London IPO had been the plan, with all bankers briefed, newly hired CEO, and a 2027 listing date floated in the press. Then the plan was changed. Boots is now in talks over a staggering $10 billion sale that would see the retailer entirely scrap its London IPO.1 That distinction matters more than the headline figure as this wasn't a forced sale, but a choice between two exits. The public one lost.

One Hundred and Seventy-Seven Years

Boots is not a distressed asset. It posted revenue growth of 3.2% to £7.5bn for the year up to August 2025, supported by new beauty brands and demand for weight-loss jabs, while pre-tax profit rose 25% to £337m.2 Sycamore hired Alex Baldock, the executive widely known for saving Currys, as their incoming CEO. A move that read clearly as IPO preparation. The asset was carved out, cleaned up, and pointed at the public markets. Then the destination changed and the float became a sale.

A Choice, Not an Accident

One pivot doesn't prove the IPO is dead, but it does suggest something is changing in how sponsors weigh their exits. They're no longer assuming the public markets will open on schedule, therefore they are pricing that uncertainty into the decision. Sycamore didn't drop the float because Boots is broken. It dropped the float because a trade sale offered something a listing no longer reliably does: a known price, on a known date.

Patient Buyers Win

So, why did a sale beat a listing? The short answer is who the buyers are. The bidders include the Weston family, through its Wittington Investments vehicle, and Australian pharmacy group, Sigma Healthcare, which has confirmed the preliminary discussions.2 For both, Boots isn't simply a retail asset. It's infrastructure, with more than 1,800 UK stores and a pharmacy arm earning steady fees from NHS-funded services. A strategic buyer can pay for the synergies it expects to capture afterwards, the bulk purchasing and shared distribution a public shareholder does not gain. In a market of uncertain listings, a buyer who values the asset more than the public market would is not just convenient. It is the better exit.

Now the Data Says It Too

Sycamore's decision matters more because the wider exit market is bearing it out. The volume of global private equity exits fell 6.25% year over year in the first quarter of 2026, to 720, and IPO exits were worth just $1.32 billion against $270.81 billion in strategic sales over the same period.3 EY's separate figures tell the same story from a different angle. Trade sales made up $121 billion of Q1 exit value while IPOs managed only $5 billion.4 The two datasets count differently, but they point in the same way. As one Preqin analyst put it, IPO markets have not broadly reopened, removing a historically important exit route.3 Sycamore choosing a sale didn't mean London was fine. It meant Sycamore was one of the sellers that found the open door first.

The Liquidity Problem Behind It

Private equity firms hold companies that can't be sold quickly, however their fund structures require them to return cash to investors on a timeline. That works until the easiest exit closes. The backlog of companies held for four years or longer has grown from roughly 13,000 to 16,000 globally, meaning more than half of all buyout-backed companies, 52%, see themselves now stuck past that mark, the highest share on record. The average holding period has of now stretched to 6.6 years.5 When the IPO window narrows, that inventory has nowhere obvious to go, and limited partners waiting on distributions start to feel the effects. One delayed exit in turn pushes the next one back. Sycamore moving now isn't proof the system is healthy. It is proof that the firms with a saleable asset are trying to get out before the queue lengthens.

Why the Trade Sale Keeps Winning

The float was one option. What replaced it is the real signal. Trade sales accounted for roughly 60% of European private equity exits in 2025, the highest share in a decade, while IPO activity stayed muted, with fewer than ten deals a year since the peak of 2021.6 Sponsors aren't choosing private sales because they prefer them in principle. They are choosing them because a guaranteed price beats a hoped-for valuation years away, and at the moment the public route can't promise either the price or the timing.

London Loses Again

There is a quieter casualty in all this which is the London market itself. A private sale would dampen hopes that Boots could help rebuild the capital's thin IPO pipeline at a time when public market activity is already under pressure. Every large asset that picks a private buyer over a float is another listing London doesn't attain. That a 177-year-old British institution is more likely to end up with a Canadian grocery dynasty or an Australian pharmacy group than on the London Stock Exchange shifts the story from "Boots is leaving" to "the exchange keeps losing the assets it most needs to keep."

A Reordering instead of a Collapse

This is not a collapse. It is a reordering of how money leaves private equity. The IPO was the prestige exit; the one sponsors planned around when markets cooperated. Now it sits behind the trade sale and the secondary as the least dependable out of the three. Private equity in 2026 is a mature industry, and the conditions that once made listings the obvious endgame have now passed.5 The Boots decision is what that maturity looks like in practice. Not panic, but a cold reassessment of which door actually opens.

Certainty Is the New Premium

Sycamore's pivot was not evidence that London is fine. It was evidence that certainty has become the thing worth paying for. A strategic buyer offers it. The public market, for now, cannot. And in private equity, the cleanest-looking exit is whichever one you can actually complete, right up until the moment you need to.

Footnotes

  1. Financial Times, Boots in talks over $10bn sale as owners look to ditch IPO plan (opens in a new tab), 9 June 2026. ↩

  2. The Grocer, Boots' owner considers £7.5bn sale instead of IPO (opens in a new tab), 10 June 2026. ↩ ↩2

  3. S&P Global Market Intelligence, Global private equity exit volume declines in Q1 2026 (opens in a new tab), 16 April 2026. ↩ ↩2

  4. EY, Private Equity Pulse: key takeaways from Q1 2026 (opens in a new tab), 29 April 2026. ↩

  5. McKinsey & Company, Global Private Equity Report 2026 (opens in a new tab), 10 February 2026. ↩ ↩2

  6. McKinsey & Company, Beating the odds: How private equity firms can improve exit prospects (opens in a new tab), 17 March 2026. ↩